Naoko Ueda

Title: Naoko Ueda: Innovator in Pharmaceutical Chemistry

Introduction

Naoko Ueda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug compounds. With a total of 5 patents to her name, Ueda's work has the potential to impact the pharmaceutical industry significantly.

Latest Patents

One of Ueda's latest patents involves a crystal of a pyrrolidine compound. This invention provides a crystal of 1-{2-[(3S,4R)-1-[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidine-3-carbonyl]-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid, which can be used as a drug substance. The invention specifically details a crystal comprising an equimolar amount of the compound and phosphoric acid. Another significant patent focuses on novel pharmaceutically acceptable salts of a morpholine derivative. This includes various forms such as malate, tartrate, hydrochloride, acetate, and naphthalene disulfonate. The invention highlights improved properties such as better crystalline state, enhanced water solubility, and increased stability.

Career Highlights

Throughout her career, Naoko Ueda has worked with notable companies, including Mitsubishi Tanabe Pharma Corporation and Mitsubishi Pharma Corporation. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations.

Collaborations

Ueda has collaborated with esteemed colleagues such as Tomohiro Yoshida and Hiroshi Sakashita. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Naoko Ueda's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in drug development and therapeutic solutions.